Cooke Julie's Form 4 filing
Neurocrine Biosciences Inc (NBIX) · filed Feb 14, 2025
- Accession no.
- 0000914475-25-000075
- Filed
- Feb 14, 2025
- Trade date
- Feb 12-13, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 4 derivative transactions. Open-market sales total $181.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cooke JulieCIK 0001776977 | Officer (Chief Human Resources Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 13, 2025 | Common Stock | MOption exerciseAcquired | +1,509 | $0.00 | $0 | 20,340 | Direct | |
| Feb 13, 2025 | Common Stock | SSaleDisposed | −796 | $116.77 | −$92,948.92 | 19,544 | Direct | |
| Feb 13, 2025 | Common Stock | MOption exerciseAcquired | +1,401 | $0.00 | $0 | 20,945 | Direct | |
| Feb 13, 2025 | Common Stock | SSaleDisposed | −755 | $116.80 | −$88,184 | 20,190 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 12, 2025 | Common Stock | AGrant or awardAcquired | +29,600 | $0.00 | $0 | 29,600 | Direct | |
| Feb 12, 2025 | Common Stock | AGrant or awardAcquired | +5,548 | $0.00 | $0 | 5,548 | Direct | |
| Feb 13, 2025 | Common Stock | MOption exerciseDisposed | −1,509 | $0.00 | $0 | 3,020 | Direct | |
| Feb 13, 2025 | Common Stock | MOption exerciseDisposed | −1,401 | $0.00 | $0 | 4,203 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.